Morningstar

Alger Health Sciences Fund Class Z AHSZX

Morningstar Medalist Rating
Medalist Rating as of | See Alger Investment Hub
  • NAV / 1-Day Return 27.47  /  +0.70 %
  • Total Assets 69.0M
  • Adj. Expense Ratio
    0.760%
  • Expense Ratio 0.760%
  • Distribution Fee Level Below Average
  • Share Class Type Institutional
  • Category Health
  • Investment Style Mid Blend
  • Min. Initial Investment 500,000
  • Status Open
  • TTM Yield 0.00
  • Turnover 289%

USD | NAV as of Jul 18, 2026 | 1-Day Return as of Jul 18, 2026, 12:40 AM GMT+0

Morningstar’s Analysis AHSZX

Will AHSZX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable AHSZX’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the AHSZX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of AHSZX’s parent organization’s priorities and whether they’re in line with investors’ interests.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Alger Health Sciences Z holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

by Morningstar Automated Analysis
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings AHSZX

More AHSZX Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 35.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Teva Pharmaceutical Industries Ltd ADR

4.58 3M
Healthcare

Impulse Dynamics Ireland Series F-3

4.56 3M
—

Forte Biosciences Inc Ordinary Shares

4.28 3M
Healthcare

Arrowhead Pharmaceuticals Inc

4.03 2M
Healthcare

Welltower Inc

3.22 2M
Real Estate

Cardinal Health Inc

3.22 2M
Healthcare

Cash

3.02 2M
Cash and Equivalents

Johnson & Johnson

2.99 2M
Healthcare

Twist Bioscience Corp

2.93 2M
Healthcare

Merck & Co Inc

2.88 2M
Healthcare

Sponsor Center